A high cannabinoid CB1 receptor immunoreactivity is associated with disease severity and outcome in prostate cancer
European Journal of Cancer2008Vol. 45(1), pp. 174–182
Citations Over TimeTop 10% of 2008 papers
Sui Chu Chung, Peter Hammarsten, Andreas Josefsson, Pär Stattin, Torvald Granfors, Lars Egevad, Giacomo Mancini, Beat Lutz, Anders Bergh, Christopher J. Fowler
Related Papers
- → Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer(1993)798 cited
- → Neuroendocrine differentiation in prostate cancer(2005)145 cited
- → Stromal Androgen Receptor Roles in the Development of Normal Prostate, Benign Prostate Hyperplasia, and Prostate Cancer(2014)89 cited
- → Abstract 561: Establishment and characterization of matched pairs of human prostate stromal cells to study cancer-stromal interaction(2010)
- → Data from Single-cell Spatial Proteomic Revelations on the Multiparametric MRI Heterogeneity of Clinically Significant Prostate Cancer(2023)